Paper36916944
Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.
Hong H and 8 others. Antimicrob Agents Chemother, 2023. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention. Papers, record 36916944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36916944
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Malaria | Major topic |
| Quinolines | Major topic |
| HIV Infections | Major topic |
| Adult | |
| Pregnancy | |
| Humans | |
| Female | |
| Chemoprevention | |
| Piperazines | |
| Alkynes | |
| Cyclopropanes | |
| Benzoxazines | |
| Artemisinins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HD059454 | NICHD NIH HHS | United States | P01HD059454 | PubMed and NIH | NIH RePORTER |
| R01 AI117001 | NIAID NIH HHS | United States | R01AI117001 | PubMed and NIH | NIH RePORTER |
| R21 AI153848 | NIAID NIH HHS | United States | R21AI153848 | PubMed and NIH | NIH RePORTER |
| UL1 TR001872 | NCATS NIH HHS | United States | UL1TR001872 | PubMed and NIH | NIH RePORTER |
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,962,728 | Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26962728 | PubMed |
| 2 | 30,715,324 | Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/30715324 | PubMed |
| 3 | 29,547,881 | Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. | Clin Infect Dis | 2018 | https://conductscience.org/library/papers/29547881 | PubMed |
| 4 | 20,002,783 | Lopinavir protein binding in HIV-1-infected pregnant women. | HIV Med | 2010 | https://conductscience.org/library/papers/20002783 | PubMed |
| 5 | 28,245,259 | Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. | PLoS Med | 2017 | https://conductscience.org/library/papers/28245259 | PubMed |
| 6 | 25,103,519 | Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. | Lancet Glob Health | 2014 | https://conductscience.org/library/papers/25103519 | PubMed |
| 7 | 34,089,711 | Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/34089711 | PubMed |
| 8 | 24,768,668 | Free phenytoin toxicity. | Am J Emerg Med | 2014 | https://conductscience.org/library/papers/24768668 | PubMed |
| 9 | 28,329,368 | Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28329368 | PubMed |
| 10 | 22,914,504 | Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women. | Antivir Ther | 2013 | https://conductscience.org/library/papers/22914504 | PubMed |
| 11 | 35,531,322 | Determination of unbound piperaquine in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry. | J Chromatogr Open | 2022 | https://conductscience.org/library/papers/35531322 | PubMed |
| 12 | 30,910,321 | Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. | Lancet | 2019 | https://conductscience.org/library/papers/30910321 | PubMed |
| 13 | 23,295,919 | Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23295919 | PubMed |
| 14 | 28,187,497 | Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28187497 | PubMed |
| 15 | 30,891,605 | Impact of Microscopic and Submicroscopic Parasitemia During Pregnancy on Placental Malaria in a High-Transmission Setting in Uganda. | J Infect Dis | 2019 | https://conductscience.org/library/papers/30891605 | PubMed |
| 16 | 33,544,819 | The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacement. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33544819 | PubMed |
| 17 | 23,221,983 | Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines. | J Acquir Immune Defic Syndr | 2013 | https://conductscience.org/library/papers/23221983 | PubMed |
| 18 | 26,889,763 | Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26889763 | PubMed |
| 19 | 14,585,213 | Protein binding in antiretroviral therapies. | AIDS Res Hum Retroviruses | 2003 | https://conductscience.org/library/papers/14585213 | PubMed |
| 20 | 11,425,175 | The burden of malaria in pregnancy in malaria-endemic areas. | Am J Trop Med Hyg | 2001 | https://conductscience.org/library/papers/11425175 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,950,582 | Unraveling the HIV-malaria interactions: a bibliometric analysis of global research trends and emerging insights. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40950582 | PubMed |
| 40,733,121 | Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733121 | PubMed |
| 40,588,993 | A Comprehensive Review on the Pharmacokinetics and Bioanalysis of Piperaquine. | Curr Drug Metab | 2025 | https://conductscience.org/library/papers/40588993 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36916944
GET https://conductscience.org/api/papers/v1/36916944/references?page=2